Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation

Cellular Signalling

Volumn 27, Issue 9, 2015, Pages 1860-1872

  Kamal, Tania ^a   Green, Taryn N ^a   Morel Kopp, Marie Christine ^b,c   Ward, Christopher M ^b,c   McGregor, Ailsa L ^a   McGlashan, Susan R ^a   Bohlander, Stefan K ^a   Browett, Peter J ^a,d   Teague, Lochie ^e   During, Matthew J ^a,f,g   Skerry, Timothy M ^h   Josefsson, Emma C ^i,j   Kalev Zylinska, Maggie L ^a,k  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^f OHIO STATE UNIVERSITY   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

Blood; Cancer; Leukemia; Megakaryocyte; Memantine; N methyl D aspartate receptor

Indexed keywords

CALCIUM; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ACUTE MEGAKARYOCYTIC LEUKEMIA; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; K-562 CELL LINE; MALE; METABOLISM; PATHOLOGY;

CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GLUTAMIC ACID; HUMANS; K562 CELLS; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MALE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84934435067     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.05.004     Document Type: Article

References (53)

1. Verkhratsky A., Parpura V. Eur. J. Pharmacol. 2014, 739C:1-3. 10.1016/j.ejphar.2013.11.013.
2. Prevarskaya N., Ouadid-Ahidouch H., Skryma R., Shuba Y. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369:20130097. 10.1098/rstb.2013.0097.
3. Klampfl T., Gisslinger H., Harutyunyan A.S., Nivarthi H., Rumi E., Milosevic J.D., Them N.C., Berg T., Gisslinger B., Pietra D., Chen D., Vladimer G.I., Bagienski K., Milanesi C., Casetti I.C., Sant'Antonio E., Ferretti V., Elena C., Schischlik F., Cleary C., et al. N. Engl. J. Med. 2013, 369:2379-2390. 10.1056/NEJMoa1311347.
4. Nangalia J., Massie C.E., Baxter E.J., Nice F.L., Gundem G., Wedge D.C., Avezov E., Li J., Kollmann K., Kent D.G., Aziz A., Godfrey A.L., Hinton J., Martincorena I., Van Loo P., Jones A.V., Guglielmelli P., Tarpey P., Harding H.P., Fitzpatrick J.D., et al. N. Engl. J. Med. 2013, 369:2391-2405. 10.1056/NEJMoa1312542.
5. Xu W., Longo F.J., Wintermantel M.R., Jiang X., Clark R.A., DeLisle S. J. Biol. Chem. 2000, 275:36676-36682. 10.1074/jbc.M002041200.
6. Vannucchi A.M., Rotunno G., Bartalucci N., Raugei G., Carrai V., Balliu M., Mannarelli C., Pacilli A., Calabresi L., Fjerza R., Pieri L., Bosi A., Manfredini R., Guglielmelli P. Leukemia 2014, 28:1811-1818. 10.1038/leu.2014.100.
7. Shivarov V., Ivanova M., Tiu R.V. Blood Cancer J. 2014, 4. (e185). 10.1038/bcj.2014.7.
8. Di Buduo C.A., Moccia F., Battiston M., De Marco L., Mazzucato M., Moratti R., Tanzi F., Balduini A. Haematologica 2014, 99:769-778. 10.3324/haematol.2013.096859.
9. Varga-Szabo D., Braun A., Nieswandt B. J. Thromb. Haemost. 2009, 7:1057-1066. 10.1111/j.1538-7836.2009.03455.x.
10. Mahaut-Smith M.P. J. Thromb. Haemost. 2012, 10:1722-1732. 10.1111/j.1538-7836.2012.04837.x.
11. Genever P.G., Wilkinson D.J., Patton A.J., Peet N.M., Hong Y., Mathur A., Erusalimsky J.D., Skerry T.M. Blood 1999, 93:2876-2883.
12. Hitchcock I.S., Skerry T.M., Howard M.R., Genever P.G. Blood 2003, 102:1254-1259. 10.1182/blood-2002-11-3553.
13. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Pharmacol. Rev. 2010, 62:405-496. 10.1124/pr.109.002451.
14. Thompson C.J., Schilling T., Howard M.R., Genever P.G. Exp. Hematol. 2010, 38:504-515. 10.1016/j.exphem.2010.03.011.
15. Robert S.M., Sontheimer H. Cell. Mol. Life Sci. 2014, 71:1839-1854. 10.1007/s00018-013-1521-z.
16. D'Mello S.A., Flanagan J.U., Green T.N., Leung E.Y., Askarian-Amiri M.E., Joseph W.R., McCrystal M.R., Isaacs R.J., Shaw J.H., Furneaux C.E., During M.J., Finlay G.J., Baguley B.C., Kalev-Zylinska M.L. Front. Oncol. 2014, 3. (e333). 10.3389/fonc.2013.00333.
17. Li L., Hanahan D. Cell 2013, 153:86-100. 10.1016/j.cell.2013.02.051.
18. Prickett T.D., Zerlanko B.J., Hill V.K., Gartner J.J., Qutob N., Jiang J., Simaan M., Wunderlich J., Gutkind J.S., Rosenberg S.A., Samuels Y. J. Invest. Dermatol. 2014, 134:2390-2398. 10.1038/jid.2014.190.
19. Rabellino E.M., Levene R.B., Leung L.L., Nachman R.L. J. Exp. Med. 1981, 154:88-100.
20. Ogura M., Morishima Y., Ohno R., Kato Y., Hirabayashi N., Nagura H., Saito H. Blood 1985, 66:1384-1392.
21. Uozumi K., Otsuka M., Ohno N., Moriyama T., Suzuki S., Shimotakahara S., Matsumura I., Hanada S., Arima T. Leukemia 2000, 14:142-152.
22. Tabilio A., Pelicci P.G., Vinci G., Mannoni P., Civin C.I., Vainchenker W., Testa U., Lipinski M., Rochant H., Breton-Gorius J. Cancer Res. 1983, 43:4569-4574.
23. Chen H.S., Lipton S.A. J. Neurochem. 2006, 97:1611-1626. 10.1111/j.1471-4159.2006.03991.x.
24. Doble A. Neurology 1996, 47:S233-S241.
25. Lamanauskas N., Nistri A. Eur. J. Neurosci. 2008, 27:2501-2514. 10.1111/j.1460-9568.2008.06211.x.
26. Choi H., Pereira A.R., Cao Z., Shuman C.F., Engene N., Byrum T., Matainaho T., Murray T.F., Mangoni A., Gerwick W.H. J. Nat. Prod. 2010, 73:1411-1421. 10.1021/np100468n.
27. Kalev-Zylinska M.L., Green T.N., Morel-Kopp M.-C., Sun P.P., Park Y.E., Lasham A., During M.J., Ward C.M. Thromb. Res. 2014, 133:837-847. 10.1016/j.thromres.2014.02.011.
28. Collingridge G.L., Olsen R.W., Peters J., Spedding M. Neuropharmacology 2009, 56:2-5. 10.1016/j.neuropharm.2008.06.063.
29. Sanz-Clemente A., Nicoll R.A., Roche K.W. Neuroscientist 2013, 19:62-75. 10.1177/1073858411435129.
30. Cohen L.D., Zuchman R., Sorokina O., Muller A., Dieterich D.C., Armstrong J.D., Ziv T., Ziv N.E. PLoS One 2013, 8. (e63191). 10.1371/journal.pone.0063191.
31. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cui J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., Zhang D. Nature 2002, 415:793-798. 10.1038/nature715.
32. Arundine M., Tymianski M. Cell. Mol. Life Sci. 2004, 61:657-668. 10.1007/s00018-003-3319-x.
33. Scott D.B., Blanpied T.A., Swanson G.T., Zhang C., Ehlers M.D. J. Neurosci. 2001, 21:3063-3072.
34. Traynelis S.F., Hartley M., Heinemann S.F. Science 1995, 268:873-876.
35. Ikeda M. Thromb. Res. 2007, 119:343-353. 10.1016/j.thromres.2006.03.007.
36. Thornton S., Schedel A., Besenfelder S., Kluter H., Bugert P. Platelets 2011, 22:390-395. 10.3109/09537104.2010.551304.
37. Paoletti P., Bellone C., Zhou Q. Nat. Rev. Neurosci. 2013, 14:383-400. 10.1038/nrn3504.
38. Henson M.A., Roberts A.C., Perez-Otano I., Philpot B.D. Prog. Neurobiol. 2010, 91:23-37. 10.1016/j.pneurobio.2010.01.004.
39. Watanabe M., Inoue Y., Sakimura K., Mishina M. Neuroreport 1992, 3:1138-1140.
40. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Neuron 1994, 12:529-540.
41. Wyllie D.J., Livesey M.R., Hardingham G.E. Neuropharmacology 2013, 74:4-17. 10.1016/j.neuropharm.2013.01.016.
42. Pachernegg S., Strutz-Seebohm N., Hollmann M. Trends Neurosci. 2012, 35:240-249. 10.1016/j.tins.2011.11.010.
43. Hansen K.B., Traynelis S.F. J. Neurosci. 2011, 31:3650-3661. 10.1523/JNEUROSCI.5565-10.2011.
44. Hansen K.B., Ogden K.K., Traynelis S.F. J. Neurosci. 2012, 32:6197-6208. 10.1523/JNEUROSCI.5757-11.2012.
45. Edman S., McKay S., Macdonald L.J., Samadi M., Livesey M.R., Hardingham G.E., Wyllie D.J. Neuropharmacology 2012, 63:441-449. 10.1016/j.neuropharm.2012.04.027.
46. Dubois C., Vanden Abeele F.A., Lehen'kyi V., Gkika D., Guarmit B., Lepage G., Slomianny C., Borowiec A.S., Bidaux G., Benahmed M., Shuba Y., Prevarskaya N. Cancer Cell 2014, 26:19-32. 10.1016/j.ccr.2014.04.025.
47. Hardingham G.E., Bading H. Nat. Rev. Neurosci. 2010, 11:682-696. 10.1038/nrn2911.
48. Bading H. Nat. Rev. Neurosci. 2013, 14:593-608. 10.1038/nrn3531.
49. Bartlett T.E., Wang Y.T. Neuropharmacology 2013, 74:59-68. 10.1016/j.neuropharm.2013.01.012.
50. Mattson M.P. Ann. N. Y. Acad. Sci. 2008, 1144:97-112. 10.1196/annals.1418.005.
51. Kotermanski S.E., Johnson J.W. J. Neurosci. 2009, 29:2774-2779. 10.1523/JNEUROSCI.3703-08.2009.
52. Wood L.K., Langford S.J. J. Med. Chem. 2014, 57:6316-6331. 10.1021/jm5001584.
53. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A. Nat. Methods 2012, 9:676-682. 10.1038/nmeth.2019.